BioSpace News Archive

Free-to-Member virtual doctor visits for seniors and others through Teladoc; providing virtual care now an option for insurer’s network of doctors

To better support its store team members during the COVID-19 pandemic, while also continuing to meet the needs of customers and communities, Walgreens has adjusted its operating hours.

CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, today announced that it will commence testing for the novel coronavirus, or COVID-19.

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc.

New research, published March 16 in Nature Communications, shows how antibodies could benefit lupus patients with nervous system dysfunction.

Roivant Sciences today announced that it has engaged with regulators in the United States, Europe, and Asia to rapidly advance the clinical development of gimsilumab for the treatment of acute respiratory distress syndrome (ARDS) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to start a Phase 2 clinical trial of Thrombosomes in bleeding patients with thrombocytopenia.

Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, has nationally launched the SureLOK MIS 3L Percutaneous Screw System, which provides spine surgeons with outstanding versatility and flexibility in terms of procedural approaches and application of its various components

The AAE announced several recommended considerations to its 8,000-plus endodontist and dentist members amid COVID-19.

In the news release issued on March 17, 2020 by Diffusion Pharmaceuticals Inc. under the same headline, please note that the third statement by the company’s chairman and chief executive officer, David Kalergis, has been clarified.